A Randomized, Parallel Group, Open Label, to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD06 Cream Versus Comp01 Cream in Subjects With Moderate to Severe Plaque Psoriasis

Trial Profile

A Randomized, Parallel Group, Open Label, to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD06 Cream Versus Comp01 Cream in Subjects With Moderate to Severe Plaque Psoriasis

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Oct 2016

At a glance

  • Drugs DFD 06 (Primary) ; Corticosteroid
  • Indications Plaque psoriasis
  • Focus Adverse reactions
  • Sponsors Promius Pharma
  • Most Recent Events

    • 01 Aug 2016 Status changed from active, no longer recruiting to completed.
    • 13 May 2016 Planned End Date changed from 1 Apr 2016 to 1 Jun 2016.
    • 09 Mar 2016 Planned End Date changed from 1 Feb 2016 to 1 Apr 2016, as reported by clinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top